Sign Out
Before any injection, patients must be asked if they have a history of allergic reactions or intolerance.
Patent Blue may cause anaphylactic shock and must only be administered in an establishment capable of adequate treatment. In the event of an allergic reaction, an investigation must be carried out determine whether, among all the medicinal products used during the operation and general anesthesia, Patent Blue is actually responsible. This result is important in the event of subsequent surgery (for contralateral cancer, for example).
When marking the sentinel node, all staff caring for the patient must be trained in the technique.
Data in literature show that the rate of identification is improved by carrying out double detection with a radiopharmaceutical and a dye.
Effects on Ability to Drive and Use Machines: Not applicable.
Continue with Google